Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMichelle A.J. van Oeteren, Nynke Simons, Marjo P.H. van de Waarenburg, Alfons J.H.M. Houben, Martijn C.G.J. Brouwers, Jean L.J.M. Scheijen
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Sugar-sweetened beverage intakes among adults between 1990 and 2018 in 185 countries
10.1038/s41467-023-41269-8 · 2023
Global disease burden attributed to high sugar-sweetened beverages in 204 countries and territories from 1990 to 2019
10.1016/j.ypmed.2023.107690 · 2023
Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial
10.1093/ajcn/nqaa332 · 2021
Comment on Lee et al. Relation of change or substitution of low-and no-calorie sweetened beverages with cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies
10.2337/dc21-2130 · 2022
Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts
10.1080/07315724.2014.916237 · 2014
Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries
10.1038/s41591-024-03345-4 · 2025
Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases
10.3945/an.116.013912 · 2017
Glycation, receptor-mediated cell activation and vascular complications of diabetes
10.3132/dvdr.2004.002 · 2004
datacite
Confidence 0%
Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
10.3390/ijms24010152 · 2022
Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study
10.2337/dc10-1087 · 2011
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons
10.1016/j.nbd.2016.02.005 · 2016
Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats
10.1074/jbc.ra119.010744 · 2019
Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes
10.1016/j.jbc.2024.107479 · 2024
The extra-splanchnic fructose escape after ingestion of a fructose-glucose drink: An exploratory study in healthy humans using a dual fructose isotope method
10.1016/j.clnesp.2018.11.008 · 2019
Unresolved referenced work
Kept as external metadata until matched
ethical principles for medical research involving human subjects
10.1001/jama.2013.281053 · 2013
Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content
10.1210/jc.2018-02795 · 2019
Fructose consumption in the Netherlands: the Dutch national food consumption survey 2007–2010
10.1038/ejcn.2014.267 · 2015
Protein-Bound Plasma Nε-(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity-Related Increase in Inflammation: The Hoorn and CODAM Studies
10.1161/atvbaha.115.306106 · 2015
Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults
10.3945/jn.111.143172 · 2011
Advanced glycation end-products and arterial stiffness in hypertension
10.1016/j.amjhyper.2006.08.009 · 2007
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
10.1136/bmjdrc-2021-002667 · 2022
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus
10.1111/dme.13201 · 2016
Plasma Advanced Glycation End Products Are Associated With Incident Cardiovascular Events in Individuals With Type 2 Diabetes: A Case-Cohort Study With a Median Follow-up of 10 Years (EPIC-NL)
10.2337/db13-1864 · 2014
Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes
10.1007/s00125-005-1810-7 · 2005
Nonenzymatic Glycation of Bovine Serum Albumin by Fructose (Fructation): Comparison with the Maillard reaction initiated by glucose
10.1016/s0021-9258(19)84904-9 · 1989
Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice
10.1152/ajpgi.00450.2012 · 2013
Accumulation of Advanced Glycation Endproducts in Aging Male Fischer 344 Rats during Long-Term Feeding of Various Dietary Carbohydrates
10.1093/jn/130.5.1247 · 2000
Advanced glycation end-product pentosidine accumulates in various tissues of rats with high fructose intake
10.33549/physiolres.931093 · 2008
Fructose-induced AGEs-RAGE signaling in skeletal muscle contributes to impairment of glucose homeostasis
10.1016/j.jnutbio.2019.05.016 · 2019
The effects of dietary fructose on blood pressure are modified by the food matrix
10.1016/j.clnu.2025.10.017 · 2025
Endogenous fructose production in patients and mice with aldolase B deficiency
2026
Kidney and vascular function in adult patients with hereditary fructose intolerance
2020
Advanced glycation end products and the kidney
10.1152/ajprenal.00398.2004 · 2005
Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity
2022
Protein glycation - biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
10.1016/j.redox.2021.101920 · 2021
No additional external references are available.